Back

Antagonist binding actively disrupts interleukin-1 receptor dynamics to block co-receptor recruitment

Nithin, C.; Fasemire, A.; Kmiecik, S.

2026-01-29 molecular biology
10.64898/2026.01.27.701974 bioRxiv
Show abstract

The interleukin-1 receptor type 1 (IL1R1) is a central regulator of inflammatory signaling and functions as a molecular switch, yet it remains unclear how agonists and antagonists that bind the same primary site produce opposite signaling outcomes. Available structural data define inactive and active endpoint conformations but do not explain how antagonist binding dynamically prevents co-receptor recruitment. Here, we combine all-atom molecular dynamics simulations with multiscale flexibility modeling using CABS-flex to systematically compare the intrinsic dynamics of IL1R1 across its unbound, agonist-bound, antagonist-bound, and co-receptor-bound states. Although both agonists and antagonists engage the same conserved interface on the D1/D2 domains, they induce fundamentally different dynamic responses in the receptor. Agonist binding progressively stabilizes interdomain coupling and promotes a stepwise transition toward a signaling-competent conformation. In contrast, antagonist binding selectively increases flexibility of the distal D3 domain, particularly at the co-receptor binding interface, thereby preventing progression along the activation pathway. Importantly, the interaction patterns and dynamic signatures observed in the simulations are consistent with experimentally identified binding determinants, mutational data, and structural features associated with receptor activation and inhibition. These results demonstrate that IL1R1 antagonism is an active, allosteric, dynamics-driven process rather than a simple failure to stabilize an active conformation. Together, this work provides a mechanistic framework that reconciles existing structural and functional observations and highlights receptor dynamics as a key determinant of signaling control in the interleukin-1 system.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
eLife
5422 papers in training set
Top 1%
17.9%
2
Cell Reports
1338 papers in training set
Top 1%
14.1%
3
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 6%
9.9%
4
Nature Communications
4913 papers in training set
Top 19%
9.9%
50% of probability mass above
5
Molecular Cell
308 papers in training set
Top 3%
4.8%
6
PLOS Computational Biology
1633 papers in training set
Top 9%
3.9%
7
Structure
175 papers in training set
Top 0.9%
3.5%
8
Science Signaling
55 papers in training set
Top 0.1%
2.7%
9
Science
429 papers in training set
Top 12%
2.1%
10
Computational and Structural Biotechnology Journal
216 papers in training set
Top 3%
2.0%
11
Nucleic Acids Research
1128 papers in training set
Top 10%
1.9%
12
PLOS Biology
408 papers in training set
Top 9%
1.7%
13
Journal of Molecular Biology
217 papers in training set
Top 2%
1.7%
14
Scientific Reports
3102 papers in training set
Top 61%
1.6%
15
Journal of the American Chemical Society
199 papers in training set
Top 3%
1.5%
16
Biophysical Journal
545 papers in training set
Top 4%
1.3%
17
Cell Systems
167 papers in training set
Top 9%
1.3%
18
Frontiers in Immunology
586 papers in training set
Top 6%
0.9%
19
PLOS Pathogens
721 papers in training set
Top 8%
0.9%
20
Communications Biology
886 papers in training set
Top 22%
0.8%
21
PLOS ONE
4510 papers in training set
Top 69%
0.7%
22
Science Advances
1098 papers in training set
Top 30%
0.7%
23
iScience
1063 papers in training set
Top 33%
0.7%
24
JACS Au
35 papers in training set
Top 1%
0.7%
25
Advanced Science
249 papers in training set
Top 22%
0.6%
26
Journal of Biological Chemistry
641 papers in training set
Top 5%
0.6%
27
Developmental Cell
168 papers in training set
Top 13%
0.6%